| First Author | Wang H | Year | 2023 |
| Journal | J Biol Chem | Volume | 299 |
| Issue | 4 | Pages | 103045 |
| PubMed ID | 36822326 | Mgi Jnum | J:335041 |
| Mgi Id | MGI:7450332 | Doi | 10.1016/j.jbc.2023.103045 |
| Citation | Wang H, et al. (2023) The signaling protein GIV/Girdin mediates the Nephrin-dependent insulin secretion of pancreatic islet beta cells in response to high glucose. J Biol Chem 299(4):103045 |
| abstractText | Glucose-stimulated insulin secretion of pancreatic beta cells is essential in maintaining glucose homeostasis. Recent evidence suggests that the Nephrin-mediated intercellular junction between beta cells is implicated in the regulation of insulin secretion. However, the underlying mechanisms are only partially characterized. Herein we report that GIV is a signaling mediator coordinating glucose-stimulated Nephrin phosphorylation and endocytosis with insulin secretion. We demonstrate that GIV is expressed in mouse islets and cultured beta cells. The loss of function study suggests that GIV is essential for the second phase of glucose-stimulated insulin secretion. Next, we demonstrate that GIV mediates the high glucose-stimulated tyrosine phosphorylation of GIV and Nephrin by recruiting Src kinase, which leads to the endocytosis of Nephrin. Subsequently, the glucose-induced GIV/Nephrin/Src signaling events trigger downstream Akt phosphorylation, which activates Rac1-mediated cytoskeleton reorganization, allowing insulin secretory granules to access the plasma membrane for the second-phase secretion. Finally, we found that GIV is downregulated in the islets isolated from diabetic mice, and rescue of GIV ameliorates the beta-cell dysfunction to restore the glucose-stimulated insulin secretion. We conclude that the GIV/Nephrin/Akt signaling axis is vital to regulate glucose-stimulated insulin secretion. This mechanism might be further targeted for therapeutic intervention of diabetic mellitus. |
